With over 20 years of experience in antibody engineering and biologics development, ProteoGenix supports biotechnology and pharmaceutical companies with reliable antibody discovery services and advanced screening technologies.
4 weeks from antigen to antibody
Rapid antibody discovery workflows enable identification of high-affinity candidates within four weeks from antigen submission.
Proven success with challenging antigens
Validated experience across GPCRs, ion channels, membrane proteins, virus-like particles, and other difficult targets.
Skip 3 weeks of humanization
Our fully human antibody solutions help reduce downstream development time and accelerate therapeutic antibody development.
Antibody Discovery for Complex Targets
Proteogenix is the market leader in antibody discovery for complex targets. Whether you’re working with GPCRs, virus-like particles, or MHC peptides, we excel where others struggle. Our expertise spans innovative techniques including NANOBODY® protein service and custom CAR-T cell development, delivering breakthrough solutions that drive your success. Having performed thousands of complex projects, our team of expert can guide you to choose the best method for your project.
Facing challenges with a complex antigen?
Discover our specialized services or contact our team to bring your project to life!
Custom Anti-GPCR Antibodies Custom Virus-Like Particle Antibodies
Custom MHC-peptide complex antibody Find a solution with our experts
Find Your Perfect Match: Tailored Antibody Discovery Platforms for Your Unique Project
Ideal for rare epitopes and optimal developability
Generate fully-human antibodies with superior drug-like properties from humanized mice. Perfect when targeting rare epitopes or when developability is critical for therapeutic success.
Hybridoma Development Service
Cost-effective solution with natural affinity maturation
An economical approach leveraging in vivo affinity maturation. Best suited for projects requiring reliable antibodies with budget-friendly cost.
Rapid human antibody generation with specialized libraries
The fastest route to fully human antibodies. Our unique cancer and autoimmune libraries maximize your chances of high-affinity binders for disease-related targets. Ideal for toxic or poorly immunogenic antigens.
Tool
Answer a few questions and find the technology that best fits your target, application and timeline.
Why ProteoGenix
As an experienced antibody discovery company, ProteoGenix supports programs from antigen strategy through lead selection and optimization — with integrated CRO capabilities across discovery, engineering, production, and characterization.
Deep Scientific Experience
Our long track record in antibody and protein science helps design robust discovery plans aligned with real therapeutic goals.
Reliable Execution
Established workflows and experienced teams improve consistency, reproducibility, and confidence in the discovery process.
Long-Term Development Support
We support clients beyond discovery with antibody engineering, production, and characterization services as programs advance. For biotech and pharma teams, working with a company with long-standing technical depth reduces uncertainty and supports faster progress toward therapeutic leads.
Navigate Antibody Discovery with Confidence and Control
Your dedicated PhD expert partners with you from project conception to completion. Benefit from specialized scientific expertise and strategic insights that ensure seamless progress at every stage of development.
“Throughout the project, we greatly benefited from ProteoGenix’s strong scientific and technical expertise, as well as the dedication and responsiveness of our main contact. Their support was instrumental in overcoming key challenges and in accelerating the translational development of our lead candidate.”
_ Dr. Uwe Haberkorn (Head of Department) at Heidelberg University
*NANOBODY® compound is a registered trademark of Ablynx N.V.
FAQ
Partner with ProteoGenix for antibody discovery services backed by scientific depth, platform capabilities, and more than 20 years of experience in antibody and biologics development. Our integrated CRO model supports biotech and pharma teams from early target analysis through lead optimization and beyond.
